RYBREVANT® is a targeted antibody* that works against by:

RYBREVANT® blocks EGFR activity

Helping stop the activity cancer cells use to grow and spread

RYBREVANT® combats EGFR cells

Working with your body's immune system to help destroy the cancer

RYBREVANT® is different than chemotherapy, immunotherapy, and TKls (tyrosine kinase inhibitors)

*Antibodies are protective proteins that help detect harmful substances and diseases such as cancers. They are made naturally by your immune system and can also be man-made. Man-made antibodies used to treat cancer have a specific target on a cancer cell that they aim to find, attach to, and attack. RYBREVANT® is a man-made antibody.

EGFR+ = mutated epidermal growth factor receptor; NSCLC = non–small cell lung cancer

Side effects

There are side effects that you may experience during treatment with RYBREVANT®.

See side effectsGrey right arrow icon
Doctor discussing possible side effects with RYBREVANT® patientDoctor discussing possible side effects with RYBREVANT® patient

Savings & support

Once prescribed a RYBREVANT®-based treatment, connect with a Care Navigator for your support needs.

Rybrevant withMe logo with patientRybrevant withMe logo with patient
The support and resources provided by RYBREVANT withMe are not intended to provide medical advice, replace a treatment plan you receive from your doctor or nurse, or serve as a reason for you to start or stay on treatment.